|
|
|
|
| LEADER |
01402cas a22005057a 4500 |
| 001 |
CENRE-914 |
| 003 |
AR-BaUEN |
| 005 |
20201012192757.0 |
| 008 |
200918c19589999nyue||p ||| 00| b0eng|d |
| 040 |
|
|
|a AR-BaUEN
|b spa
|c AR-BaUEN
|
| 022 |
|
|
|a 0006-2952
|
| 044 |
|
|
|a xxu
|
| 080 |
|
|
|a 577.1
|b E6b3p3 (57I)
|
| 210 |
1 |
|
|a Biochem. pharmacol.
|
| 245 |
0 |
0 |
|a Biochemical Pharmacology
|
| 260 |
|
|
|a New York (655 Avenue of the Americas New York, NY 10010-5107) :
|b Elsevier Science Inc,
|c 1958-
|
| 310 |
|
|
|a Quincenal
|
| 650 |
1 |
7 |
|2 spines
|a BIOLOGIA
|
| 650 |
1 |
7 |
|2 spines
|a BIOFISICA
|
| 650 |
1 |
7 |
|2 spines
|a BIOQUIMICA
|
| 650 |
1 |
7 |
|2 spines
|a FARMACOLOGIA
|
| 650 |
1 |
7 |
|2 spines
|a TOXICOLOGIA
|
| 866 |
4 |
1 |
|a 1960 5(1-3)
|
| 866 |
4 |
1 |
|a 1961 6(1-4)
|
| 866 |
4 |
1 |
|a 1961 8(1)
|
| 866 |
4 |
1 |
|a 1962 9C
|
| 866 |
4 |
1 |
|a 1963 12(10,12)
|
| 866 |
4 |
1 |
|a 1964 13(2,4,7-8,10,12)
|
| 866 |
4 |
1 |
|a 1965-1966 14-15(1-12)C
|
| 866 |
4 |
1 |
|a 1967 16(1-3,5-12)
|
| 866 |
4 |
1 |
|a 1968 17(1-6,8-12)
|
| 866 |
4 |
1 |
|a 1969 18(1-12)C
|
| 866 |
4 |
1 |
|a 1970 19(1-4)
|
| 866 |
4 |
1 |
|a 1982 31(4,6,9,11)
|
| 866 |
4 |
1 |
|a 1987-1989 36-38(1-24)C
|
| 866 |
4 |
1 |
|a 1990-1991 39-41(1-12)C
|
| 866 |
4 |
1 |
|a 1991 42(1-3,5-12)
|
| 866 |
4 |
1 |
|a 1992 43(1-12)C
|
| 866 |
4 |
1 |
|a 1993 44(1-10,12)
|
| 866 |
4 |
1 |
|a 1993 45(1-12)C
|
| 866 |
4 |
1 |
|a 1993 46(1-4,6-12)
|
| 866 |
4 |
1 |
|a 1994 47(1,3-12)
|
| 866 |
4 |
1 |
|a 1994-1996 48-51(1-12)C
|
| 866 |
4 |
1 |
|a 1996 52(2-12)
|
| 999 |
|
|
|c 52030
|